Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-06

FDA Approved: DUAVEE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for Duavee (conjugated estrogens/bazedoxifene) submitted by Wyeth Pharmaceuticals (Pfizer) to update the product's appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duavee (bazedoxifene/conjugated estrogens)

Snippet

SUPPL AP for DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE)